Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High serum galectin-3 in advanced melanoma: preliminary results.
Vereecken P, Zouaoui Boudjeltia K, Debray C, Awada A, Legssyer I, Sales F, Petein M, Vanhaeverbeek M, Ghanem G, Heenen M. Vereecken P, et al. Among authors: legssyer i. Clin Exp Dermatol. 2006 Jan;31(1):105-9. doi: 10.1111/j.1365-2230.2005.01992.x. Clin Exp Dermatol. 2006. PMID: 16309497
Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Van Antwerpen P, Legssyer I, Zouaoui Boudjeltia K, Babar S, Moreau P, Moguilevsky N, Vanhaeverbeek M, Ducobu J, Nève J. Van Antwerpen P, et al. Among authors: legssyer i. Eur J Pharmacol. 2006 May 10;537(1-3):31-6. doi: 10.1016/j.ejphar.2006.03.022. Epub 2006 Mar 20. Eur J Pharmacol. 2006. PMID: 16631159
Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation.
Zouaoui Boudjeltia K, Moguilevsky N, Legssyer I, Babar S, Guillaume M, Delree P, Vanhaeverbeek M, Brohee D, Ducobu J, Remacle C. Zouaoui Boudjeltia K, et al. Among authors: legssyer i. Biochem Biophys Res Commun. 2004 Dec 10;325(2):434-8. doi: 10.1016/j.bbrc.2004.10.049. Biochem Biophys Res Commun. 2004. PMID: 15530411
Triggering of inflammatory response by myeloperoxidase-oxidized LDL.
Boudjeltia KZ, Legssyer I, Van Antwerpen P, Kisoka RL, Babar S, Moguilevsky N, Delree P, Ducobu J, Remacle C, Vanhaeverbeek M, Brohee D. Boudjeltia KZ, et al. Among authors: legssyer i. Biochem Cell Biol. 2006 Oct;84(5):805-12. doi: 10.1139/o06-061. Biochem Cell Biol. 2006. PMID: 17167545
Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis.
Van Antwerpen P, Néve J, Moreau P, Boudjeltia KZ, Vanhaeverbeek M, Prévost M, Babar S, Legssyer I, Moguilevsky N, Ducobu J. Van Antwerpen P, et al. Among authors: legssyer i. J Cardiovasc Pharmacol. 2007 Sep;50(3):350-1. doi: 10.1097/FJC.0b013e31809501dc. J Cardiovasc Pharmacol. 2007. PMID: 17878766 No abstract available.
Allergic Bronchopulmonary Aspergillosis: A Case Report.
Bouali S, Legssyer I, Thouil A, Kouismi H. Bouali S, et al. Among authors: legssyer i. Cureus. 2023 May 9;15(5):e38778. doi: 10.7759/cureus.38778. eCollection 2023 May. Cureus. 2023. PMID: 37303384 Free PMC article.